Neurocrine Biosciences | Der Umsatz





Der Umsatz Veränderung Datum
AbbVie USD 16.62B 840M 2025-12
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 12.9M 450K 2025-09
ALKERMES USD 394.2M 3.5M 2025-09
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Cytokinetics USD 1.93M 64.83M 2025-09
Dynavax Technologies USD 94.9M 540K 2025-09
Exelixis USD 597.8M 29.5M 2025-09
Gilead Sciences USD 7.8B 700M 2025-09
Halozyme Therapeutics USD 354M 148M 2025-09
Incyte USD 1.37B 310M 2025-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Neurocrine Biosciences USD 794.9M 107.4M 2025-09
Pfizer USD 17.58B 880M 2025-12
Prothena USD 2.42M 2M 2025-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Repligen USD 189M 7M 2025-09
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Neurocrine Biosciences Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.